1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Myriad Pharmaceuticals

Anonymous board for Myriad Pharmaceuticals

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    421
  2. Anonymous
    Replies:
    33
    Views:
    17,981
  3. anonymous
    Replies:
    0
    Views:
    795
  4. anonymous
    Replies:
    2
    Views:
    666
  5. anonymous
    Replies:
    1
    Views:
    492
  6. anonymous
    Replies:
    13
    Views:
    4,406
  7. anonymous
    Replies:
    0
    Views:
    674
  8. anonymous
    Replies:
    3
    Views:
    1,655
  9. Anonymous
    Replies:
    0
    Views:
    1,047
  10. anonymous
    Replies:
    3
    Views:
    1,824
  11. Anonymous
    Replies:
    44
    Views:
    31,404
  12. anonymous
    Replies:
    3
    Views:
    4,417
  13. anonymous
    Replies:
    5
    Views:
    1,807
  14. Anonymous
    Replies:
    5
    Views:
    5,127
  15. Doctor Sam
    Replies:
    1
    Views:
    1,696
  16. anonymous
    Replies:
    0
    Views:
    1,420
  17. anonymous
    Replies:
    2
    Views:
    1,586
  18. anonymous
    Replies:
    2
    Views:
    5,212
  19. anonymous
    Replies:
    2
    Views:
    3,010
  20. anonymous
    Replies:
    0
    Views:
    2,684

Thread Display Options

Loading...